Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection - sprookjes - yvandenbroek - TriplyDB

Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

http://www.wikidata.org/entity/Q35202828

about

Memory of infections: an emerging role for natural killer cells Longitudinal Analysis of Natural Killer Cells in Dengue Virus-Infected Patients in Comparison to Chikungunya and Chikungunya/Dengue Virus-Infected Patients NK Cells in HIV Disease Human NK Cell Diversity in Viral Infection: Ramifications of Ramification The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy Activating KIRs and NKG2C in Viral Infections: Toward NK Cell Memory?Infectious Mononucleosis Innate Immune Memory: The Latest Frontier of Adjuvanticity Molecular characterization of HCMV-specific immune responses: Parallels between CD8(+) T cells, CD4(+) T cells, and NK cells Natural killer cell biology: an update and future directions Immune regulation of human herpesviruses and its implications for human transplantation Immunological memory within the innate immune system Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease Human cytomegalovirus infection elicits new decidual natural killer cell effector functions.Functional Reconstitution of Natural Killer Cells in Allogeneic Hematopoietic Stem Cell Transplantation Features of Memory-Like and PD-1(+) Human NK Cell Subsets Harnessing adaptive natural killer cells in cancer immunotherapy Infectious mononucleosis.Boosting vaccine efficacy the natural (killer) way IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion Proteome analysis of distinct developmental stages of human natural killer (NK) cells The natural killer cell response to West Nile virus in young and old individuals with or without a prior history of infection Know Thyself: NK-Cell Inhibitory Receptors Prompt Self-Tolerance, Education, and Viral Control.Cutting edge: NKG2C(hi)CD57+ NK cells respond specifically to acute infection with cytomegalovirus and not Epstein-Barr virus.Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients.Independent skewing of the T cell and NK cell compartments associated with cytomegalovirus infection suggests division of labor between innate and adaptive immunity.Hepatitis C Virus and Human Cytomegalovirus-Natural Killer Cell Subsets in Persistent Viral Infections.Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia.IL-21-dependent expansion of memory-like NK cells enhances protective immune responses against Mycobacterium tuberculosis.Proapoptotic Bim regulates antigen-specific NK cell contraction and the generation of the memory NK cell pool after cytomegalovirus infection.Persistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy.Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy.Inhibition of the TRAIL death receptor by CMV reveals its importance in NK cell-mediated antiviral defense.Characterization of natural killer cell phenotype and function during recurrent human HSV-2 infection.Role for early-differentiated natural killer cells in infectious mononucleosis Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions.Balancing natural killer cell activation through paired receptors.Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation

P2860

Q21131375-A3613A69-E594-45A4-87D4-FB0A7E1C9CD9 Q24288747-F7C8E694-B9D4-4D1B-91B1-137BF7920A2A Q26752833-0C7BB5A0-61EE-4DCF-B65F-DA0F00675AB1 Q26765925-3B7E8B59-F98F-4A76-938F-D0ACBE53F0DD Q26768481-4859FB93-B6FD-4F99-8952-5DB0F86F9EBC Q26771449-B4A69AA1-0193-49BE-A8DF-89EF51B84B00 Q26776114-29631968-558C-4051-80F7-FA293E77641C Q26783692-599B4040-0923-411B-919C-CD45D59EE471 Q26783968-226A5959-0137-471D-AF0C-A26337D84DC7 Q26801288-9AFAE652-DD28-44F2-BAC6-8A35A1048D83 Q26830512-C95DEE33-DF6D-4802-A3DF-F599A53310AF Q26992146-BF71F365-ED6F-4666-8536-98ABF2D6574B Q27001211-DB546B6F-7B90-477E-934D-E07548F20FA4 Q27022458-F7ED0499-7808-47FF-873D-6551C4BA7A7F Q27335494-B9BE5659-1904-44C3-8F16-9F323F82CBBF Q28069682-15CDC782-68A0-45D4-A246-F8DC74150115 Q28073988-1848FD28-5A47-4654-8327-D918111C7683 Q28081448-4744EA68-A539-476A-8EA4-2B59AF43B069 Q28084340-2C684C91-99B7-44DF-B647-F24AF5DAFE7D Q28084474-D3F4C8F6-35F5-450E-9DF2-E431EE99167B Q28251295-CB9685B8-1AB5-45DB-9742-21F0F7244ECB Q28704450-92ACC3D5-B65D-4133-9BBB-D97664F23C54 Q29365826-DF0440C6-9B34-450F-A0FA-D5F7D44B5A37 Q30413217-0905ACDD-27F0-445E-A71D-D95ED218EDA5 Q33580199-6D152D3A-9F30-4DB5-A726-4F9A6C2B889F Q33646189-955ABD5F-6C33-485D-8AEA-7B32547D82B6 Q33671980-F51EAAD9-1B32-4606-9510-C5675239FF82 Q33689001-3BB9B96F-D2F2-400D-80DC-F394D366378C Q33694920-10A5B20D-97DE-4AA2-A179-AA5E8D28B925 Q33734571-26F96663-0F7E-4F2D-9388-FB6CF780F249 Q33774531-2000EE9F-D01E-4CA1-8BA6-7DAB4DFB18B1 Q33826867-6FFF214A-2522-49AC-90D5-6DAE4A3E6F7E Q33854427-F457630E-36ED-40BF-AF99-CE4F86937413 Q33905311-B9CA77A8-F80A-4D3D-A506-0BA9A3F28E47 Q34047484-0323183A-8EA0-41BE-9E43-9A39F1BC4FD0 Q34081693-70964F2B-1A3F-48A6-A88C-BCB358308550 Q34353708-E81D310E-9682-4177-8BA4-3E57824C7A4D Q34390895-64295DBE-11B0-42AA-B247-654CDC3F86F1 Q34465877-F5FCB1D9-54E5-4897-94D7-11046D3A36FC Q34533074-DAE04E9D-6967-48C4-A522-9198687B5348

P2860

Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

http://www.wikidata.org/entity/Q35202828

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Expansion of a unique CD57⁺NKG ...... uman cytomegalovirus infection

@ast

Expansion of a unique CD57⁺NKG ...... uman cytomegalovirus infection

@en

type

label

Expansion of a unique CD57⁺NKG ...... uman cytomegalovirus infection

@ast

Expansion of a unique CD57⁺NKG ...... uman cytomegalovirus infection

@en

prefLabel

Expansion of a unique CD57⁺NKG ...... uman cytomegalovirus infection

@ast

Expansion of a unique CD57⁺NKG ...... uman cytomegalovirus infection

@en

P1433

Q35202828-E356EED6-1095-40D0-9B3F-AC2F9857936F

P1476

Q35202828-E904B88D-2D74-4E94-B426-F3AA3CBE45CA

P2093

Q35202828-15A1CED9-A612-463D-A5CC-E8855EFD5C58

Q35202828-1CF043C4-0BD5-4148-ADDC-84DD38E08BD5

Q35202828-333C9AE2-EB0A-42D1-9D5C-2B4828B5010D

Q35202828-4EDF0F53-4CF0-41E4-8B49-D62C6B8301A1

Q35202828-8D55E612-A4FE-46F3-B292-C39FD4A6AE8D

Q35202828-9C75D822-F66F-4C2C-9E99-8AE49955633A

Q35202828-9F31F84C-0C09-45C4-9391-A09E25F40A11

Q35202828-CE603A74-EDE8-432B-B825-539C09CE26A8

Q35202828-DC98E5C3-E11D-48C4-B40A-4841FB41BD48

Q35202828-EFF04D2D-7BC6-4A4B-8B7B-F3143519B4B4

P2860

Q35202828-009DD28E-DD2B-4229-A9DD-4C283863A282

Q35202828-00A0DDC8-7C99-40EE-AA1A-FDFE014DAC73

Q35202828-092956F6-8D35-48BB-8126-FF90CA2AA584

Q35202828-0E1CCE56-B4C2-4E85-B3AF-689BC862DED3

Q35202828-1DB1471C-461F-4015-B519-12AD6561EEC9

Q35202828-1E094F2C-5AE2-4FC1-B010-2AD9BF2E7C8F

Q35202828-24F6AF4E-98EF-4F86-B9F2-D319CAB65640

Q35202828-2B6BA24D-56EB-45A0-A1B6-FB7059294160

Q35202828-31906E1E-22B6-4555-8D47-A695EBB65ECD

Q35202828-32814CDE-3558-4681-8F39-C0D05BB7EA4B

P304

Q35202828-74232D08-9EA5-43B4-BE07-A4052AE8A9F7

P31

Q35202828-661E90FA-7990-4062-9E46-18321C79D12C

P356

Q35202828-4B8D755B-C120-4728-9125-E79C3B4FB6E0

P407

Q35202828-8B7F66EB-26BF-43A6-B26B-FDE1ECD4B37A

P433

Q35202828-119A9007-B43B-4B59-B82C-3CB32FEABEE6

P478

Q35202828-F6ED2B21-7DCB-4040-BA52-C3B0B3D1A5A1

P50

Q35202828-09AB6E44-FEA9-4944-9CEB-EE45D51DEC5D

Q35202828-9EC3293F-506D-4964-B557-5CCA4EEE6B76

P577

Q35202828-1A5CBFBE-C30A-40A4-AA76-7C7DE1C11292

P5875

Q35202828-AC762FFB-09A6-4255-8163-2621EF17FF0E

P698

Q35202828-95F59A51-5D82-49A6-A87F-A906EAE5E815

P921

Q35202828-8037FC0B-4E86-4835-AAAF-AAB513BC2F9F

P932

Q35202828-90101078-4408-4412-AC45-E6713C05CB40

P356

PNAS.1110900108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Expansion of a unique CD57⁺NKG ...... uman cytomegalovirus infection

@en

P2093

Brian S Schwartz

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Milush

http://www.w3.org/2001/XMLSchema#string

Jeffrey P Houchins

http://www.w3.org/2001/XMLSchema#string

Jessica Jarjoura

http://www.w3.org/2001/XMLSchema#string

Lewis L Lanier

http://www.w3.org/2001/XMLSchema#string

Phillip J Norris

http://www.w3.org/2001/XMLSchema#string

Sandra Lopez-Vergès

http://www.w3.org/2001/XMLSchema#string

Sang-Mo Kang

http://www.w3.org/2001/XMLSchema#string

Steve Miller

http://www.w3.org/2001/XMLSchema#string

Vanessa A York

http://www.w3.org/2001/XMLSchema#string

P2860

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells

Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein

UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells

Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

Association of DAP12 with activating CD94/NKG2C NK cell receptors

Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors

Innate or adaptive immunity? The example of natural killer cells

Up on the tightrope: natural killer cell activation and inhibition

P304

14725-14732

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1110900108

http://www.w3.org/2001/XMLSchema#string

P407

P433

36

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Douglas F. Nixon

Marcelo J Pando

P577

2011-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51555576

http://www.w3.org/2001/XMLSchema#string

P698

21825173

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

3169160

http://www.w3.org/2001/XMLSchema#string